Eshelman School of Pharmacy, University of North Carolina, 1 University Heights, CPO 2125, Asheville, NC, 28804, USA.
School of Pharmacy, University College London, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.
Curr Allergy Asthma Rep. 2018 Aug 25;18(10):53. doi: 10.1007/s11882-018-0809-3.
Although portable electronic spirometers allow for at-home lung function monitoring, a comprehensive review of these devices has not yet been conducted. We conducted a systematic search and review of commercially available portable electronic spirometers designed for asthma patient use.
All devices (N = 16) allowed for monitoring of basic lung function parameters, but only 31% provided in-app videos on how to perform breathing maneuvers. Most devices (63%) provided graphical representations of lung function results, but only 44% gave immediate feedback on the quality of the breathing maneuver. Several devices (25%) were FDA-approved and cost ranged from US$99 to $1390. Information on data security (63%), measurement accuracy (50%), and association with patient outcomes (0%) was commonly limited. This review found that providers' ability to make informed decisions about whether asthma patients may benefit from portable electronic spirometers is limited due to lack of patient outcome data.
虽然便携式电子肺活量计可用于家庭肺功能监测，但尚未对这些设备进行全面综述。我们对专为哮喘患者设计的市售便携式电子肺活量计进行了系统的搜索和综述。
所有设备（N=16）均允许监测基本肺功能参数，但仅有 31%的设备提供了有关如何进行呼吸动作的应用内视频。大多数设备（63%）提供了肺功能结果的图形表示，但仅有 44%的设备对呼吸动作的质量提供即时反馈。部分设备（25%）获得了 FDA 批准，价格范围为 99 美元至 1390 美元。有关数据安全性（63%）、测量准确性（50%）和与患者结局的关联（0%）的信息通常有限。本综述发现，由于缺乏患者结局数据，提供者对于哮喘患者是否可能受益于便携式电子肺活量计做出明智决策的能力受到限制。
